Bausch Health Cos EBIT Margin 2010-2023 | BHC
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Bausch Health Cos (BHC) over the last 10 years. The current EBIT profit margin for Bausch Health Cos as of December 31, 2023 is .
| Bausch Health Cos EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2023-12-31 |
$8.76B |
$0.96B |
11.00% |
| 2023-09-30 |
$8.54B |
$0.37B |
4.33% |
| 2023-06-30 |
$8.35B |
$0.60B |
7.19% |
| 2023-03-31 |
$8.15B |
$0.35B |
4.28% |
| 2022-12-31 |
$8.12B |
$0.45B |
5.59% |
| 2022-09-30 |
$8.13B |
$1.07B |
13.10% |
| 2022-06-30 |
$8.19B |
$1.40B |
17.03% |
| 2022-03-31 |
$8.33B |
$0.96B |
11.58% |
| 2021-12-31 |
$8.43B |
$0.45B |
5.34% |
| 2021-09-30 |
$8.45B |
$0.08B |
0.92% |
| 2021-06-30 |
$8.48B |
$-0.04B |
-0.42% |
| 2021-03-31 |
$8.04B |
$0.21B |
2.57% |
| 2020-12-31 |
$8.03B |
$0.68B |
8.42% |
| 2020-09-30 |
$8.04B |
$-0.40B |
-4.91% |
| 2020-06-30 |
$8.11B |
$-0.53B |
-6.49% |
| 2020-03-31 |
$8.60B |
$-0.24B |
-2.81% |
| 2019-12-31 |
$8.60B |
$-0.20B |
-2.36% |
| 2019-09-30 |
$8.50B |
$0.90B |
10.57% |
| 2019-06-30 |
$8.43B |
$0.69B |
8.14% |
| 2019-03-31 |
$8.40B |
$0.18B |
2.19% |
| 2018-12-31 |
$8.38B |
$-2.38B |
-28.45% |
| 2018-09-30 |
$8.42B |
$-2.73B |
-32.43% |
| 2018-06-30 |
$8.51B |
$-2.81B |
-33.04% |
| 2018-03-31 |
$8.61B |
$-2.39B |
-27.76% |
| 2017-12-31 |
$8.72B |
$0.10B |
1.17% |
| 2017-09-30 |
$8.96B |
$0.57B |
6.40% |
| 2017-06-30 |
$9.22B |
$-0.33B |
-3.55% |
| 2017-03-31 |
$9.41B |
$-0.42B |
-4.47% |
| 2016-12-31 |
$9.67B |
$-0.57B |
-5.85% |
| 2016-09-30 |
$10.03B |
$-0.55B |
-5.47% |
| 2016-06-30 |
$10.34B |
$0.76B |
7.37% |
| 2016-03-31 |
$10.65B |
$1.02B |
9.61% |
| 2015-12-31 |
$10.45B |
$1.53B |
14.63% |
| 2015-09-30 |
$9.91B |
$1.97B |
19.83% |
| 2015-06-30 |
$9.18B |
$2.20B |
23.98% |
| 2015-03-31 |
$8.49B |
$2.22B |
26.09% |
| 2014-12-31 |
$8.21B |
$2.00B |
24.38% |
| 2014-09-30 |
$8.05B |
$1.62B |
20.13% |
| 2014-06-30 |
$7.53B |
$0.04B |
0.58% |
| 2014-03-31 |
$6.59B |
$-0.17B |
-2.58% |
| 2013-12-31 |
$5.77B |
$-0.41B |
-7.11% |
| 2013-09-30 |
$4.63B |
$-0.73B |
-15.82% |
| 2013-06-30 |
$3.97B |
$0.19B |
4.76% |
| 2013-03-31 |
$3.69B |
$0.14B |
3.66% |
| 2012-12-31 |
$3.48B |
$0.08B |
2.27% |
| 2012-09-30 |
$3.21B |
$0.17B |
5.32% |
| 2012-06-30 |
$2.93B |
$0.25B |
8.67% |
| 2012-03-31 |
$2.72B |
$0.29B |
10.49% |
| 2011-12-31 |
$2.43B |
$0.30B |
12.32% |
| 2011-09-30 |
$2.29B |
$0.26B |
11.18% |
| 2011-06-30 |
$1.90B |
$0.02B |
0.95% |
| 2011-03-31 |
$1.53B |
$-0.05B |
-3.34% |
| 2010-12-31 |
$1.18B |
$-0.11B |
-9.31% |
| 2010-09-30 |
$0.91B |
$-0.00B |
-0.22% |
| 2010-06-30 |
$0.91B |
$0.18B |
19.93% |
| 2010-03-31 |
$0.87B |
$0.14B |
16.59% |
| 2009-12-31 |
$0.82B |
$0.18B |
22.17% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.201B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
